NCT02051608 A Study of Gantenerumab in Participants With Mild Alzheimer Disease Status COMPLETED Phase PHASE3
NCT02051335 Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults Status COMPLETED Phase PHASE1
NCT02051244 Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease? Status UNKNOWN Phase N/A
NCT02035982 Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT02033941 Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD) Status TERMINATED Phase PHASE2
NCT02031198 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02029547 Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians Status WITHDRAWN Phase NA
NCT02022943 Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies Status RECRUITING Phase N/A
NCT02018913 Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study Status UNKNOWN Phase N/A
NCT02017340 A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT02016560 Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Status COMPLETED Phase PHASE2/PHASE3
NCT02010476 Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men Status COMPLETED Phase N/A
NCT02006654 Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor Status COMPLETED Phase PHASE3
NCT02006641 Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil Status COMPLETED Phase PHASE3